89bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
24.63
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
6
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.80
|
-0.57
|
0.23
|
28.75%
|
|
2022-06-30
|
-1.05
|
-1.23
|
-0.18
|
-17.14%
|
|
2022-03-31
|
-1.29
|
-1.26
|
0.03
|
2.33%
|
|
2021-12-31
|
-1.31
|
-1.30
|
0.01
|
0.76%
|
|
2021-09-30
|
-1.06
|
-1.41
|
-0.35
|
-33.02%
|
|
2021-06-30
|
-0.84
|
-1.03
|
-0.19
|
-22.62%
|
|
2021-03-31
|
-0.69
|
-0.74
|
-0.05
|
-7.25%
|
|
2020-12-31
|
-0.87
|
-0.63
|
0.24
|
27.59%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.06
|
|
2021-12-31
|
-4.48
|
|
2020-12-31
|
-3.10
|
|
2019-12-31
|
-33.21
|